Presentation is loading. Please wait.

Presentation is loading. Please wait.

Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma  Arianna.

Similar presentations


Presentation on theme: "Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma  Arianna."— Presentation transcript:

1 Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma  Arianna Barbetta, MD, Meier Hsu, MS, Kay See Tan, PhD, Dessislava Stefanova, MD, Koby Herman, MD, Prasad S. Adusumilli, MD, Manjit S. Bains, MD, Matthew J. Bott, MD, James M. Isbell, MD, Yelena Y. Janjigian, MD, Geoffrey Y. Ku, MD, Bernard J. Park, MD, Abraham J. Wu, MD, David R. Jones, MD, Daniela Molena, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 155, Issue 6, Pages e3 (June 2018) DOI: /j.jtcvs Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Overall survival, stratified according to treatment. CRT, Chemoradiotherapy; trimodality, neoadjuvant chemoradiotherapy followed by surgery; CI, confidence interval. The Journal of Thoracic and Cardiovascular Surgery  , e3DOI: ( /j.jtcvs ) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 Kaplan–Meier curve showing disease-free survival, stratified according to treatment group. CRT, Chemoradiotherapy; trimodality, neoadjuvant chemoradiotherapy followed by surgery; CI, confidence interval. The Journal of Thoracic and Cardiovascular Surgery  , e3DOI: ( /j.jtcvs ) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

4 Figure 3 Cumulative incidence of local recurrence (LR). CRT, Chemoradiotherapy; trimodality, neoadjuvant chemoradiotherapy followed by surgery; CI, confidence interval. The Journal of Thoracic and Cardiovascular Surgery  , e3DOI: ( /j.jtcvs ) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

5 Figure 4 Cumulative incidence of regional (A) and distant (B) recurrence. RR, Regional recurrence; CRT, chemoradiotherapy; trimodality, neoadjuvant chemoradiotherapy followed by surgery; CI, confidence interval; DR, distant recurrence. The Journal of Thoracic and Cardiovascular Surgery  , e3DOI: ( /j.jtcvs ) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

6 Figure E1 Consolidated Standards of Reporting Trials flow diagram showing selection of patients included in the current study, on the basis of inclusion and exclusion criteria. SCC, Squamous cell carcinoma; cStage, clinical stage; CRT, chemoradiotherapy; trimodality, neoadjuvant chemoradiotherapy followed by surgery. The Journal of Thoracic and Cardiovascular Surgery  , e3DOI: ( /j.jtcvs ) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

7 Overall survival stratified according to treatment.
The Journal of Thoracic and Cardiovascular Surgery  , e3DOI: ( /j.jtcvs ) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

8 Video 1 Daniela Molena, MD, discussing the implications of the study. Video available at: The Journal of Thoracic and Cardiovascular Surgery  , e3DOI: ( /j.jtcvs ) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

9 The Journal of Thoracic and Cardiovascular Surgery 2018 155, 2710-2721
The Journal of Thoracic and Cardiovascular Surgery  , e3DOI: ( /j.jtcvs ) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions


Download ppt "Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma  Arianna."

Similar presentations


Ads by Google